Finance

Beta
Ask
Lists
530233:BOM
Auro Laboratories Ltd
₹254.90
+0.16%
(+0.40) 1D
Jun 23, 9:51:06 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 530233...
Open
₹254.90
High
₹254.90
Low
₹254.90
Mkt. cap
1.59B
Avg. vol.
3.23K
Volume
44.00
P/E ratio
44.96
52-wk high
₹317.00
52-wk low
₹159.00
EPS
₹5.67
Shares outstanding
6.23M
No. of employees
55
Open
₹254.90
High
₹254.90
Low
₹254.90
Mkt. cap
1.59B
Avg. vol.
3.23K
Volume
44.00
P/E ratio
44.96
52-wk high
₹317.00
52-wk low
₹159.00
EPS
₹5.67
Shares outstanding
6.23M
No. of employees
55
News stories
From sources across the web
About Auro Laboratories Ltd
CEO-
Employees55
Founded1989
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
27.74M
88.37M
93.93M
98.32M
Cost of goods sold
9.00M
19.72M
11.23M
20.38M
Cost of revenue
9.00M
19.72M
11.23M
20.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.91M
14.52M
15.88M
19.95M
Operating expense
21.15M
51.58M
51.87M
53.72M
Total operating expenses
30.15M
71.30M
63.09M
74.10M
Operating income
-2.41M
17.06M
30.84M
24.23M
Other non operating income
4.16M
9.76M
1.77M
6.64M
EBT including unusual items
-1.06M
17.20M
17.38M
14.55M
EBT excluding unusual items
-1.06M
17.20M
17.38M
16.00M
Income tax expense
-
10.04M
-2.13M
4.85M
Effective tax rate
-
58.38%
-12.28%
33.30%
Other operating expenses
13.50M
30.55M
26.17M
24.73M
Net income
-1.06M
7.16M
19.52M
9.71M
Net profit margin
-3.80%
8.10%
20.78%
9.87%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.81M
-9.62M
-15.22M
-14.87M
Net interest expenses
-2.81M
-9.62M
-15.22M
-14.87M
Depreciation and amortization charges
2.74M
6.51M
9.82M
9.04M
EBITDA
328.50K
21.69M
33.58M
31.26M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more